-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Harmony Biosciences Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2024.
- Harmony Biosciences Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $6.68M, a 48.9% decline year-over-year.
- Harmony Biosciences Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $46.3M, a 3.97% increase year-over-year.
- Harmony Biosciences Holdings, Inc. annual Income Tax Expense (Benefit) for 2024 was $46.3M, a 3.97% increase from 2023.
- Harmony Biosciences Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was $44.5M.
- Harmony Biosciences Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was -$76.8M, a 2812% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)